1. Home
  2. LEGN vs KBR Comparison

LEGN vs KBR Comparison

Compare LEGN & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • KBR
  • Stock Information
  • Founded
  • LEGN 2014
  • KBR 1901
  • Country
  • LEGN United States
  • KBR United States
  • Employees
  • LEGN N/A
  • KBR N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • KBR Military/Government/Technical
  • Sector
  • LEGN Health Care
  • KBR Industrials
  • Exchange
  • LEGN Nasdaq
  • KBR Nasdaq
  • Market Cap
  • LEGN 5.4B
  • KBR 6.4B
  • IPO Year
  • LEGN 2020
  • KBR 2006
  • Fundamental
  • Price
  • LEGN $35.56
  • KBR $51.07
  • Analyst Decision
  • LEGN Strong Buy
  • KBR Buy
  • Analyst Count
  • LEGN 10
  • KBR 8
  • Target Price
  • LEGN $73.67
  • KBR $60.29
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • KBR 1.5M
  • Earning Date
  • LEGN 08-11-2025
  • KBR 07-31-2025
  • Dividend Yield
  • LEGN N/A
  • KBR 1.29%
  • EPS Growth
  • LEGN N/A
  • KBR 86.03
  • EPS
  • LEGN N/A
  • KBR 2.75
  • Revenue
  • LEGN $796,838,000.00
  • KBR $8,047,000,000.00
  • Revenue This Year
  • LEGN $66.76
  • KBR $11.69
  • Revenue Next Year
  • LEGN $52.58
  • KBR $6.58
  • P/E Ratio
  • LEGN N/A
  • KBR $18.55
  • Revenue Growth
  • LEGN 74.75
  • KBR 12.31
  • 52 Week Low
  • LEGN $27.34
  • KBR $43.89
  • 52 Week High
  • LEGN $59.62
  • KBR $72.60
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 35.54
  • KBR 64.28
  • Support Level
  • LEGN $35.10
  • KBR $49.33
  • Resistance Level
  • LEGN $38.35
  • KBR $50.22
  • Average True Range (ATR)
  • LEGN 1.31
  • KBR 1.01
  • MACD
  • LEGN -0.37
  • KBR 0.17
  • Stochastic Oscillator
  • LEGN 11.33
  • KBR 100.00

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About KBR KBR Inc.

KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.

Share on Social Networks: